Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma

This study has been completed.
Sponsor:
Collaborator:
Pfizer
Information provided by:
Nycomed
ClinicalTrials.gov Identifier:
NCT01365533
First received: May 30, 2011
Last updated: May 4, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2005
  Primary Completion Date: July 2005 (Final data collection date for primary outcome measure)
No publications provided by Nycomed

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):